3-rx.comCustomer Support3-rx.com
Find a product
    HomeAbout UsFAQContactHelp
 
   
 
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics
Online Pharmacy



Personality disorders are chronic mental disorders


Join our Mailing List

Men`s Health sites at Top100biz.com




Syndicate

You are here : 3-RX.com > Home > AIDS/HIV -

HIV screening not just for the young

AIDS/HIVJun 17, 08

Screening for HIV infection in people older than 55 years of age is likely to be worthwhile in terms of the cost of screening balanced against the potential savings in heath care costs and the gain in years of life, according to a report in the Annals of Internal Medicine.

Recent guidelines by the U.S Centers for Disease Control and Prevention recommend screening for HIV infection in everyone between 13 and 64 years of age. Whether screening is cost-effective for people in the 55-to-75 age range, however, was unclear.

The cost and benefits of screening depend on the total expense of testing and counseling, the amount of disease in the community and how likely any given person is to be infected, and the potential benefits when the disease is caught early.

Dr. Gillian D. Sanders, from Duke University in Durham, North Carolina, and colleagues calculate that streamlined counseling and HIV screening of 65-year-old people would cost less than $60,000 for every quality-adjusted life-year saved, even in areas where only 1 in 1000 people are infected.

That cost-benefit ratio compares favorably with other interventions considered worthwhile, the team points out.

“Advanced age alone should not preclude screening for HIV. Rather, for many people in this age group, the cost-effectiveness of screening is within the range of that of other accepted interventions,” the investigators conclude.

SOURCE: Annals of Internal Medicine, June 17, 2008.



Print Version
Tell-a-Friend

RELATED ARTICLES:
  Delay in AIDS drug use in South Africa costly
  Protein identified that turns off HIV-fighting T cells
  Study examines repeated exposure to HIV in treatment-suppressed HIV patients
  Markers of inflammation and blood-clotting tied to hazards of intermittent HIV treatment
  What HIV Needs: Identification of Human Factors May Yield Novel Therapeutic Targets for HIV
  HIV Status Unknown for Most “Negative” Men Online
  A Young Woman’s Battle With HIV
  WHO publishes how-to guide on fighting AIDS
  African ex-leaders to press politicians over AIDS
  Mexicans in U.S. illegally at more risk of AIDS
  Government to release revised U.S. HIV estimates
  U.S. drops trial of one AIDS vaccine

 


Advertisement
















Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site